Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 26, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of share transactions rather than a financial performance report.
Material Changes
The filing details a specific transaction on April 24, 2006, where Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust, transferred 6,156 Ordinary Shares. These shares were transferred on behalf of participants in the SmithKline Beecham Employee Share Option Plan 1991.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) are interested in shares held in the GSK Trust in the same capacity as other employees or former employees. The transaction was notified in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: April 24, 2006.
- Shares Transferred: 6,156 Ordinary Shares.
- Trustee: Abacus (GSK) Trustees Limited (GSK Trust).
- Plan Involved: SmithKline Beecham Employee Share Option Plan 1991.
- Directors with Interest: Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop.